In THCA, DIO3 is silenced due to epigenetic modification, and demethylating agents combined with inhibitors can restore its expression; in HCC, Wnt pathway activation leads to high DIO3 expression, promoting cell cycle and inhibiting apoptosis through the pathway. Here, DIO3 is linked to hepatocellular carcinoma.